CompaniesPriavoid

Priavoid

active

Düsseldorf, Germany

Founded 2017

About

All-d-peptides

Areas of Focus

Categories

Gene Therapy, RNA & Peptide Therapy

Team (2)

Philipp Bürling

Philipp Bürling, MBA

Prof. Dr. med. Oliver Peters

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

304

By Phase

PHASE2: 1

By Status

ACTIVE_NOT_RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2022

2023

2024

2025

2026

2027

Today

Hover over trial bars to see details

Recent Trials

NCT06182085Collaborator

Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)

PHASE2Active, not recruiting

304 participants

Started: Dec 1, 2023 · Completed: Apr 30, 2026

Locations (1)

Headquarters

Düsseldorf, Germany

Map

Loading map...